Application of 3153-26-2, Because a catalyst decreases the height of the energy barrier, its presence increases the reaction rates of both the forward and the reverse reactions by the same amount.3153-26-2, Name is Vanadyl acetylacetonate, molecular formula is C10H14O5V. In a article，once mentioned of 3153-26-2
A series of mononuclear non-oxido vanadium(IV) [VIV(L1-4)2] (1-4), oxidoethoxido vanadium(V) [VVO(L1-4)(OEt)] (5-8), and dinuclear mu-oxidodioxidodivanadium(V) [VV2O3(L1)2] (9) complexes with tridentate aroylazine ligands are reported [H2L1 = 2-furoylazine of 2-hydroxy-1-acetonaphthone, H2L2 = 2-thiophenoylazine of 2-hydroxy-1-acetonaphthone, H2L3 = 1-naphthoylazine of 2-hydroxy-1-acetonaphthone, H2L4 = 3-hydroxy-2-naphthoylazine of 2-hydroxy-1-acetonaphthone]. The complexes are characterized by elemental analysis, by various spectroscopic techniques, and by single-crystal X-ray diffraction (for 2, 3, 5, 6, 8, and 9). The non-oxido VIV complexes (1-4) are quite stable in open air as well as in solution, and DFT calculations allow predicting EPR and UV-vis spectra and the electronic structure. The solution behavior of the [VVO(L1-4)(OEt)] compounds (5-8) is studied confirming the formation of at least two different types of VV species in solution, monomeric corresponding to 5-8, and mu-oxidodioxidodivanadium [VV2O3(L1-4)2] compounds. The mu-oxidodioxidodivanadium compound [VV2O3(L1)2] (9), generated from the corresponding mononuclear complex [VVO(L1)(OEt)] (5), is characterized in solution and in the solid state. The single-crystal X-ray diffraction analyses of the non-oxido vanadium(IV) compounds (2 and 3) show a N2O4 binding set and a trigonal prismatic geometry, and those of the VVO complexes 5, 6, and 8 and the mu-oxidodioxidodivanadium(V) (9) reveal that the metal center is in a distorted square pyramidal geometry with O4N binding sets. For the mu-oxidodioxidodivanadium species in equilibrium with 5-8 in CH2Cl2, no mixed-valence complexes are detected by chronocoulometric and EPR studies. However, upon progressive transfer of two electrons, two distinct monomeric VIVO species are detected and characterized by EPR spectroscopy and DFT calculations.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 3153-26-2, and how the biochemistry of the body works.Application of 3153-26-2
Reference：
Metal catalyst and ligand design,
Ligand Template Strategies for Catalyst Encapsulation – NCBI